SEC Form 4 · accession 0001179110-15-008136
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregg H Alton
Officer — EVP, Corp & Med Affairs
Period of report
May 15, 2015
Accepted (ET)
May 19, 2015 · 7:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 15, 2015 | M | 24,375 | $19.085 | A | 167,797 | D | |
| Common Stock | May 15, 2015 | M | 625 | $23.60 | A | 168,422 | D | |
| Common StockF4 | May 15, 2015 | S | 25,000 | $110.0084 | D | 143,422 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $19.085 | May 15, 2015 | M | 24,375 | D | — | Jan 20, 2021 | Common Stock | 24,375 | 0 | D |
| Non-Qualified Stock Option (right to buy)F3 | $23.60 | May 15, 2015 | M | 625 | D | — | Jan 21, 2019 | Common Stock | 625 | 4,375 | D |
Explanation of responses
- F1The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- F2The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
- F3The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
- F4Sale prices reported for the transactions reported here range from $110.00 to $110.08. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.